All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

110

Reset

110 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • HEC88473Phase 21 trial

    Dongguan HEC Biopharmaceutical R&D Co., Ltd. · Type 2 Diabetes

  • HP-211Phase 21 trial

    Housey Healthcare ULC · Type 2 Diabetes

  • LY3457263Phase 21 trial

    Eli Lilly · Type 2 Diabetes

  • LY3938577Phase 21 trial

    Eli Lilly · Diabetes Mellitus, Type 2

  • MKP10241Phase 21 trial

    Mankind Pharma Limited · Type 2 Diabetes Mellitus (T2DM), Food Effect, Safety and Tolerability

  • MN-001Phase 21 trial

    MediciNova · Diabetes Mellitus, Type 2, Hypertriglyceridemia, Non-Alcoholic Fatty Liver Disease

  • NNC0662-3168Test product-APhase 21 trial

    Novo Nordisk · Overweight, Obesity, Type 2 Diabetes Mellitus

  • SAL0150Phase 21 trial

    Shenzhen Salubris Pharmaceuticals Co., Ltd. · Type 2 Diabetes Mellitus (T2DM), Type 2 Diabetes, T2DM

  • TrizepatidePhase 21 trial

    Novo Nordisk · Diabetes Mellitus, Type 2

  • VX-264Phase 21 trial

    Vertex Pharmaceuticals · Type 1 Diabetes

NewerPage 3 of 3

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.